Eisai seeks indication expansion for Pariet in Japan

Japanese pharmaceutical firm Eisai has filed an application for the proton pump inhibitor (PPI) Pariet (rabeprazole sodium, rabeprazole) in Japan for a further indication expansion for use in the prevention of recurrent gastric or duodenal ulcer caus…
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news